| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Extracting Real Benefits from Travel & Expense Management |
|
Digg It - Extracting Real Benefits from Travel & Expense Management
For your company to truly reap the rewards of a structured corporate travel policy, it must focus on one thing above all else: compliance. Unfortunately, while the explosion in convenient Self Booking Tools gives you a lot more freedom of choice, it According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product also makes compliance a great deal more challenging. Any technology that supports an increase in compliance to policy has merit; it will save your company money and bring back the benefits of corporate travel. Today's diversity of choice in self boo ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in king tools makes compliance through denial of access a very difficult protocol to enforce. What you really need is a funnel through which 100% of your company's travel activity must pass. In the corporate world, the only viable funnel is the payment lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. mechanism – getting paid is the ultimate leveler. If you use a corporate credit card as the payment mechanism, supported by a corporate expense management software solution, and suppliers who can report back to you a reasonable level of data, you sta here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe d a very good chance of supporting the compliance objective. A compliance-friendly corporate expense management software solution A corporate expense management software solution which processes card transactions (and possesses decent workfl d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ow) requires the traveler to personally justify all deviations from policy to their supervisor – on a transaction by transaction basis. Just as importantly, the warehoused individual transactions give the corporate travel manager the opportunity to c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc onduct spend analysis and examine individual and aggregate behaviors. You might argue that this is after the act, but it still encourages compliance. As per all card based procurement systems, if an employee consistently deviates from company policy easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi they may be penalized (e.g. card withdrawal, official warning, employment termination, etc.). The threat of negative repercussions acts as a deterrent to card misuse, thereby increasing the level of compliance. The benefits of policy compliance< nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically /b>
80% of the business case benefits of corporate travel will come from travel policy compliance. This requires:
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ an be channeled (the card and the corporate expense management software solution); and
There will also be some peripheral benefits to be gained from a corporate expense management softwar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi solution in the pre-trip phase: For instance:
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mails.
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod download of trip data from your TMC, and travelers can seek to match that against trip card transactions, thus reducing the quantity of manual entries required of the travel coordinator.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin provides travelers with a real-time log of commitments beyond what might be recorded in a personal diary. How does it apply to your company? In looking at the business case for this exercise, you do need to closely examine a numbe tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen of factors to determine the benefits you will actually realize:
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ss entirely within one closed loop. It is up to you to determine if you can obtain maximum purchasing power in this environment.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust he extent to which you can source the data you require from your travelers via a TMC data feed and, consequently, the keystroke savings you can achieve for those travelers.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of them setting up trip details in your corporate expense management software solution at time of booking rather than at time of arrival of the card transaction. The combination of Electronic Travel Management and Expense Management is a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de n important subset of eProcurement, and it is subject to the same challenges facing all eProcurement initiatives over the past 10 years – industry standards, supplier participation, and a seamless marketplace. Until these elements are all in place, g elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip reatest advantage will be gained by companies that focus on the big picture of where they can achieve maximum purchasing value with reasonable purchasing productivity – usually based on being able to perform an analysis of spend patterns and behavior tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Should Lawyers be allowed to Complain against Franchisors Leaders, Leaders Everywhere - Can Any of Them Think?
|